miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3

Rui Feng Li(Guangxi Institute of Botany)
Oncology Reports
July 1, 2011
Cited by 98


Related Papers